Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CV.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CV.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CV.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CV.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CV.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBKEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBKEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBKECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBKECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBKEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBKEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBKENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBKENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.14.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.14.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.14.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.14.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.14.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.14.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.14.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.14.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBK.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBK.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBK.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBK.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBK.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.25.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-16428.4South Korea
BQ.1.25.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.25.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.25.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used